Medicamen Organics
Medicamen Organics Share Price Chart
Medicamen Organics last traded at ₹24.00 (2026-10-13). Over the past month the stock moved -4.8%, three months the stock moved +0.0%, year the stock moved -27.9%. Its closing range over 52 weeks is ₹21.20 – ₹35.60, with the latest close 32.6% below the high.
Closing prices up to 2026-10-13.
About Medicamen Organics
Incorporated in 1995, Medicamen Organics Ltd develops, manufactures, and distributes a broad range of pharmaceutical dosages including generic dosage[1]
Business Overview:[1][2] MOL specializes in manufacturing and distributing tablets, capsules, syrups, and ointments. It offers B2B contract and third-party manufacturing services for pharma companies in India and globally. Its portfolio includes generic and branded formulations, catering to government sectors, private institutions, and prominent pharma firms. Products are marketed via third-party distributors and loan licensing agreements.
Fundamentals
Quarterly Results
In the latest quarter (Mar 2026), Medicamen Organics reported sales of ₹4.78 crore (-65.7%) and net profit of ₹-6.06 crore (-581.0%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 4.78 | -7.17 | -150.00 | -6.06 | -4.98 |
| Sep 2025 | 17.85 | 3.42 | 19.16 | 2.04 | 1.74 |
| Mar 2025 | 21.58 | 3.85 | 17.84 | 2.54 | 2.17 |
| Sep 2024 | 16.61 | 2.73 | 16.44 | 1.51 | 1.29 |
| Mar 2024 | 13.95 | 2.33 | 16.70 | 1.26 | 1.47 |
| Mar 2026 | |
|---|---|
| Sales growth | -65.7% |
| Operating profit growth | -407.7% |
| Net profit growth | -581.0% |
| EPS growth | -438.8% |
| OPM % | -150.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Medicamen Organics reported sales of ₹22.63 crore (-40.7%) and net profit of ₹-4.02 crore (-199.3%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 22.63 | -3.75 | -16.57 | -4.02 | -3.30 |
| Mar 2025 | 38.19 | 6.58 | 17.23 | 4.05 | 3.46 |
| Mar 2024 | 25.27 | 4.74 | 18.76 | 2.62 | 3.05 |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Sales growth | +51.1% | -40.7% |
| Operating profit growth | +38.8% | -157.0% |
| Net profit growth | +54.6% | -199.3% |
| EPS growth | +13.4% | -195.4% |
| OPM % | 17.2% | -16.6% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Medicamen Organics.
Get Free AI Stock Analysis FREE →Latest News
No recent news available for Medicamen Organics.
Frequently Asked Questions
What is the share price of Medicamen Organics today?
Medicamen Organics shares were last quoted at ₹24.00 (+2.8% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Medicamen Organics?
Medicamen Organics has a price-to-earnings (P/E) ratio of -11.20 and a price-to-book (P/B) ratio of 1.09. The industry P/E is 52.82.
What is the 52-week high and low of Medicamen Organics?
The 52-week high of Medicamen Organics is ₹38.00 and the 52-week low is ₹19.10.
What is the market cap of Medicamen Organics?
The market capitalisation of Medicamen Organics is about ₹34.15 crore.
How did Medicamen Organics perform in its latest quarterly results?
In the latest quarter (Mar 2026), Medicamen Organics reported sales of ₹4.78 crore (-65.7%) and net profit of ₹-6.06 crore (-581.0%), compared with the same quarter last year.
Is Medicamen Organics a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Medicamen Organics has a 3-year ROE of 3.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Medicamen Organics?
Promoters hold about 54.89% of Medicamen Organics.
Which sector does Medicamen Organics belong to?
Medicamen Organics belongs to the Pharmaceuticals & Drugs sector.